Mesenchymal stromal cell therapy for coronavirus disease 2019: which? when? and how much?

Mesenchymal stromal cells (MSCs) are under active consideration as a treatment strategy for controlling the hyper-inflammation and slow disease progression associated with coronavirus disease 2019 (COVID-19). The possible mechanism of protection through their immunoregulatory and paracrine action ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Shahani, Pradnya, Datta, Indrani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society for Cell & Gene Therapy. Published by Elsevier Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084615/
https://www.ncbi.nlm.nih.gov/pubmed/34053857
http://dx.doi.org/10.1016/j.jcyt.2021.04.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084615/
https://www.ncbi.nlm.nih.gov/pubmed/34053857
http://dx.doi.org/10.1016/j.jcyt.2021.04.004

Ejemplares similares